Obesity+2
Not yet recruitingPhase 3 Randomized Trial of Once‑Monthly PF‑08653944 to Reduce Breathing Events in Adults with Obstructive Sleep Apnea and Overweight/Obesity Using a PAP Machine
Phase 3 Randomized Trial of Once‑Monthly PF‑08653944 to Reduce Breathing Events in Adults with Obstructive Sleep Apnea and Overweight/Obesity Using a PAP Machine
- Disease:ObesityObstructive sleep apnoea syndrome+1
- Substances:Berobenatide
Germany- Participants:18–64 years · 65+ years
- Substances:Berobenatide
- Sponsor:Pfizer Inc.










